Gala­pa­gos plans to hand over Jy­s­e­le­ca and 400 em­ploy­ees to Al­fasig­ma, re­duce work­force by 100

Gala­pa­gos has a plan to hand over its Jy­s­e­le­ca busi­ness — its on­ly com­mer­cial prod­uct — to Al­fasig­ma, as well as lay off some of its own em­ploy­ees and trans­fer oth­ers to the Ital­ian phar­ma.

In the po­ten­tial deal, Gala­pa­gos will get €50 mil­lion ($53.3 mil­lion) up­front, po­ten­tial mile­stone pay­ments to­tal­ing €120 mil­lion ($127.9 mil­lion) and mid-sin­gle to mid-dou­ble-dig­it roy­al­ties on Eu­ro­pean sales for Al­fasig­ma. About 400 jobs in 14 dif­fer­ent Eu­ro­pean coun­tries will al­so be trans­ferred to Al­fasig­ma.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER